Continuous Dopaminergic Stimulation (CDS), different infusion rates
Objective: Physiopathological and therapeutic discussion of motor complications and dyskinesias in patients treated with continuous dopaminergic stimulation Background: Levodopa -induced motor complications remain an important…Demographic and Regional Variation in All-Cause Mortality Rates among United States Medicare Beneficiaries with Parkinson’s Disease
Objective: To determine whether all-cause mortality rates among persons with Parkinson’s disease (PD) in the United States (US) differ by sex, race/ethnicity, or geographic location.…Gut dysbiosis in patients with dementia with Lewy bodies
Objective: To identify intestinal bacteria that are changed in DLB alone or in both DLB and cognitive decline in Parkinson’s disease (PD). Background: Gut microbiota…Gerstmann-Sträussler-Scheinker disease presenting as dystonia
Objective: Gerstmann-Sträussler-Scheinker disease (GSS) is a type of human transmissible spongiform encephalopathy that is determined genetically. Background: Gerstmann-Sträussler-Scheinker disease (GSS) is a type of human…Effect of rehabilitation interventions on freezing of gait in people with Parkinson’s disease: a systematic review and meta-analyses
Objective: To summarize the effects of rehabilitation interventions to reduce freezing of gait (FOG) in people with Parkinson’s disease (PwPD). Background: FOG is a debilitating…The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson’s: a theory-informed qualitative study.
Objective: To explore experiences of people with Parkinson’s (PwP) in using technology as part of a home-based visuo-cognitive training programme compared to traditional approaches to…Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada: A Multicenter Study
Objective: To describe the demographics and clinical characteristics of Autosomal Dominant (AD) Spinocerebellar Ataxias (SCA) in the Canadian population. Background: SCAs are a group of…In vivo synaptic density in parkinsonism
Objective: To provide first evidence of in vivo binding properties of the [18F]SynVesT-1 tracer (aka [18F]-SDM-8) for the quantification of synaptic density loss in a…Social Withdrawal in Parkinson’s Disease: A Scoping Review
Objective: We conducted a scoping review to understand the nature and impacts of social withdrawal in PD and identify evidence gaps. Background: Social withdrawal has…Beta-agonists and risk of Parkinson’s disease: Meta-analysis of real-world evidence studies
Objective: We performed a systematic review and meta-analysis of real-world evidence (RWE) studies evaluating the association between use of beta-agonist and the risk of PD.…
- « Previous Page
- 1
- …
- 514
- 515
- 516
- 517
- 518
- …
- 1554
- Next Page »